市場調査レポート

パーキンソン病向け脳深部電気刺激装置市場:世界の産業分析・規模・シェア・成長・動向・予測

Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia Pacific and Rest of the World) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

発行 Transparency Market Research 商品コード 297662
出版日 ページ情報 英文 91 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
パーキンソン病向け脳深部電気刺激装置市場:世界の産業分析・規模・シェア・成長・動向・予測 Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia Pacific and Rest of the World) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
出版日: 2014年11月18日 ページ情報: 英文 91 Pages
概要

世界の人口高齢化が進むにつれ、パーキンソン病患者の数も増加しており、患者の中では脳深部電気刺激装置市場の成長をもたらす神経性の運動障害に対する認識も高まっています。世界的にみて、神経障害は主要な死因であり、死者総数の約12%を占めています。この中で、脳血管障害が死因の85%を占めています。

当レポートでは、世界におけるパーキンソン病向け脳深部電気刺激装置市場の現状と見通しについて調査分析し、主要地域・国別の市場分析、市場影響因子の分析、ポーターのファイブフォース分析、および主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 世界におけるパーキンソン病向け脳深部電気刺激装置市場の力学

  • イントロダクション
  • 市場発展因子
  • 市場発展阻害因子
  • 市場機会
  • ポーターのファイブフォース分析
  • 市場魅力分析:地域別
  • 競合情勢

第4章 パーキンソン病向け脳深部電気刺激装置市場:地域別

  • 概要
  • 北米
    • パーキンソン病の患者数:国別
    • 脳深部電気刺激装置による治療を受けたパーキンソン病患者数:国別
    • パーキンソン病向け脳深部電気刺激装置市場の収益:国別
    • 米国
    • カナダ
  • 欧州
    • パーキンソン病の患者数:国別
    • 脳深部電気刺激装置による治療を受けたパーキンソン病患者数:国別
    • パーキンソン病向け脳深部電気刺激装置市場の収益:国別
    • ドイツ
    • イタリア
    • スペイン
    • 英国
    • フランス
    • その他
  • アジア太平洋地域
    • パーキンソン病の患者数:国別
    • 脳深部電気刺激装置による治療を受けたパーキンソン病患者数:国別
    • パーキンソン病向け脳深部電気刺激装置市場の収益:国別
    • オーストラリア
    • 中国
    • インド
    • ニュージーランド
    • 日本
    • その他
  • その他の地域
    • パーキンソン病の患者数:国別
    • 脳深部電気刺激装置による治療を受けたパーキンソン病患者数:国別
    • パーキンソン病向け脳深部電気刺激装置市場の収益:国別
    • ブラジル
    • メキシコその他

第5章 提言

第6章 企業プロファイル

  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • St. Jude Medical, Inc.

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

A rise in the global geriatric population, increasing number of patients suffering from Parkinson's disease (PD) and growing awareness about neurological movement disorders among patients have triggered the growth of the deep brain stimulation devices market. Globally, neurological disorders are one of the major causes of mortality and account for approximately 12% of deaths per annum. Of these, cerebrovascular diseases account for 85% deaths. Parkinson's disease is the most common neurological disorder after Alzheimer's disease. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance. Drug therapy is the most effective treatment option available to control PD in the initial stages; however, a large number of medicines are required to control the disease during its advanced stages. In the later stages of PD, surgical treatment using deep brain stimulation (DBS) devices is used to control symptoms of the disease. DBS devices are an effective, clinically proven and legally approved advanced treatment option for mild to severe PD. The market for DBS devices is expected to grow at a significant rate during the forecast period from 2014 to 2020. However, the high cost of the surgical procedure could hamper the growth of the market. The growing burden of PD on health care systems, along with the uncertainty of economic conditions in some developed economies such as the U.S. and Europe has forced original equipment manufacturers (OEMs) to develop cost-effective devices for PD treatment.

This market research report on DBS devices for the treatment of Parkinson's disease provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of the market. The report discusses the market for deep brain stimulation devices for Parkinson's disease based on prevalence of the disease and the use of these devices to treat PD in four geographical regions: North America, Europe, Asia Pacific and Rest of the World. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information on various segments and sub-segments that are included in the scope of the study. It also provides overall information and data analysis of the global market for deep brain stimulation devices for Parkinson's disease with respect to market segments based on geography (i.e., region-wise and country-wise analyses).

The global market for DBS devices for Parkinson's disease has been segmented with respect to geography. Market size estimates and forecasts for the period from 2012 to 2020 have been provided for each geographical region in terms of revenue (USD million), considering 2012 and 2013 as historical and base years, respectively. The CAGR (%) of each market segment for the forecast period from 2014 to 2020 has also been provided along with market size estimations. The market overview section provides a detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global market for deep brain stimulation devices for the treatment of Parkinson's disease. The section also covers opportunities, Porter's five forces analysis as well as market attractiveness analysis and market share analysis of major players in the global DBS devices market.

A list of recommendations has been provided for new entrants and existing market players to help them establish a strong presence in the market and increase their share. The report also profiles the major players in the market for deep brain stimulation devices for Parkinson's disease based on various attributes. The profiles include company overview, financial overview, business strategies, product portfolio and recent developments. Prominent players profiled in the report include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and Aleva Neurotherapeutics SA.

Global deep brain stimulation devices market for Parkinson's disease is segmented as follows:

Deep Brain Stimulation Devices Market, By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)

Asia Pacific

  • Australia
  • New Zealand
  • Japan
  • India
  • China
  • Rest of Asia Pacific

Rest of the World (RoW)

  • Brazil
  • Mexico
  • Rest of RoW

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson's Disease
  • 2.2 Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's Disease, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Deep Brain Stimulation Devices Market for Parkinson's Disease Overview

  • 3.1 Introduction
  • 3.2 Market Drivers
    • 3.2.1 Rapidly Aging Population Leading to Rising Risk and High Prevalence of Neurological Disorders such as Parkinson's disease, Alzheimer's disease, Dementia, etc.
    • 3.2.2 Growing Demand for Deep Brain Stimulation Devices due to Rising Popularity of Minimally Invasive Procedures
    • 3.2.3 Favorable Reimbursement Scenario would add to the Increased Acceptance of DBS Devices Globally
    • 3.2.4 Availability of Technologically Advanced Deep Brain Stimulation Devices would Further Boost Market Growth
  • 3.3 Market Restraints
    • 3.3.1 Risks Associated with Deep Brain Stimulation Procedures
    • 3.3.2 Implementation of Certain Government Policies such as the Affordable Care Act in the U.S. Negatively Affects the DBS Devices Market
  • 3.4 Market Opportunities
    • 3.4.1 Address the High Unmet Needs of the Patient population in the Emerging Economies of the World
  • 3.5 Porter's Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's Disease
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of Substitutes
    • 3.5.4 Threat of New Entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's Disease, by Geography
  • 3.7 Competitive Landscape
    • 3.7.1 Market Share Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's disease, 2013 (Value %)

Chapter 4 Global Deep Brain Stimulation Devices Market for Parkinson's Disease, by Geography

  • 4.1 Overview
    • 4.1.1 Global Prevalence of Parkinson's Disease, by Geography, 2012 - 2020 (Number of Patients)
    • 4.1.2 Global Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Geography, 2012 - 2020
    • 4.1.3 Global Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • 4.2 North America
    • 4.2.1 North America Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
    • 4.2.2 North America Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
    • 4.2.3 North America Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
    • 4.2.4 United States
    • 4.2.4.1 United States Deep Brain Stimulation Devices Market for Parkinson's Disease Revenue, 2012 - 2020 (USD Million)
    • 4.2.5 Canada
    • 4.2.5.1 Canada Deep Brain Stimulation Devices Market for Parkinson's Disease Revenue, 2012 - 2020 (USD Million)
  • 4.3 Europe
    • 4.3.1 Europe Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
    • 4.3.2 Europe Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
    • 4.3.3 Europe Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
    • 4.3.4 Germany
    • 4.3.4.1 Germany Deep Brain Stimulation Devices Market for Parkinson's Disease Revenue, 2012 - 2020 (USD Million)
    • 4.3.5 Italy
    • 4.3.5.1 Italy Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.3.6 Spain
    • 4.3.6.1 Spain Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.3.7 United Kingdom
    • 4.3.7.1 United Kingdom Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.3.8 France
    • 4.3.8.1 France Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.3.9 Rest of Europe (RoE)
    • 4.3.9.1 RoE Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
    • 4.4.2 Asia Pacific Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
    • 4.4.3 Asia Pacific Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
    • 4.4.4 Australia
    • 4.4.4.1 Australia Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.4.5 China
    • 4.4.5.1 China Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.4.6 India
    • 4.4.6.1 India Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.4.7 New Zealand
    • 4.4.7.1 New Zealand Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.4.8 Japan
    • 4.4.8.1 Japan Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.4.9 Rest of APAC
    • 4.4.9.1 Rest of APAC Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • 4.5 Rest of the World (RoW)
    • 4.5.1 RoW Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
    • 4.5.2 RoW Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
    • 4.5.3 RoW Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
    • 4.5.4 Brazil
    • 4.5.4.1 Brazil Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.5.5 Mexico
    • 4.5.5.1 Mexico Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
    • 4.5.6 Rest of RoW
    • 4.5.6.1 Rest of RoW Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 Recommendations

  • 5.1 Improved Product Life and Reduction in the Price of DBS Devices would Create Better Prospects for Players in this Market
  • 5.2 Manufacturing of Deep Brain Stimulation Devices to be Outsourced to Contract Manufacturing Organizations
  • 5.3 Target Emerging Economies of the World for Higher Benefits
  • 5.4 Improve Public Awareness About the Disease, its Consequences as well as Treatment Options and Associated Benefits

Chapter 6 Company Profiles

  • 6.1 Aleva Neurotherapeutics SA
    • 6.1.1 Company Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Product Portfolio
    • 6.1.4 Business Strategies
    • 6.1.5 Recent Developments
  • 6.2 Boston Scientific Corporation
    • 6.2.1 Company Profile
    • 6.2.2 Financial Overview
    • 6.2.3 Product Portfolio
    • 6.2.4 Business Strategies
    • 6.2.5 Recent Developments
  • 6.3 Medtronic, Inc.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Product Portfolio
    • 6.3.4 Business Strategies
  • 6.4 St. Jude Medical, Inc.
    • 6.4.1 Company Profile
    • 6.4.2 Financial Overview
    • 6.4.3 Product Portfolio
    • 6.4.4 Business Strategies

List of Figures

  • FIG. 1 Deep Brain Stimulation Devices for Parkinson's Disease: Market Segmentation
  • FIG. 2 Global DBS Devices Market for Parkinson's Disease, by Region, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's Disease, by Geography, 2013 & 2020 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's Disease
  • FIG. 5 Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson's Disease, by Geography (2013)
  • FIG. 6 Market Share by Key Players: Global Deep Brain Stimulation Devices Market for Parkinson's disease, 2013 (Value %)
  • FIG. 7 United States Deep Brain Stimulation Devices Market for Parkinson's Disease Revenue, 2012 - 2020 (USD Million)
  • FIG. 8 Canada Deep Brain Stimulation Devices Market for Parkinson's Disease Revenue, 2012 - 2020 (USD Million)
  • FIG. 9 Germany Deep Brain Stimulation Devices Market for Parkinson's Disease Revenue, 2012 - 2020 (USD Million)
  • FIG. 10 Italy Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11 Spain Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12 United Kingdom Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13 France Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14 RoE Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15 Australia Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16 China Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17 India Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18 New Zealand Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19 Japan Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20 Rest of APAC Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21 Brazil Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 22 Mexico Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 23 Rest of RoW Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 24 Boston Scientific Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25 Medtronic, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26 St. Jude Medical, Inc.: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson's Disease
  • TABLE 2 Relationship Between Age and the Occurrence of Parkinson's Disease
  • TABLE 3 Deep Brain Stimulation Device's U.S. FDA approval for Various Neurological Disorders
  • TABLE 4 Global Prevalence of Parkinson's Disease, by Geography, 2012 - 2020 (Number of Patients)
  • TABLE 5 Global Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Geography, 2012 - 2020
  • TABLE 6 Global Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Geography, 2012 - 2020 (USD Million)
  • TABLE 7 North America Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
  • TABLE 8 North America Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
  • TABLE 9 North America Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
  • TABLE 10 Europe Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
  • TABLE 11 Europe Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
  • TABLE 12 Europe Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
  • TABLE 13 Asia Pacific Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
  • TABLE 14 Asia Pacific Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
  • TABLE 15 Asia Pacific Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
  • TABLE 16 RoW Prevalence of Parkinson's Disease, by Country, 2012 - 2020 (Number of Patients)
  • TABLE 17 RoW Number of Patients with Parkinson's Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 - 2020
  • TABLE 18 RoW Deep Brain Stimulation Devices for Parkinson's Disease Market Revenue, by Country, 2012 - 2020 (USD Million)
Back to Top